title: Effect of D-002 on acetic acid-induced colitis in rats at single and repeated doses.
abstract: D-002 is a natural mixture of higher aliphatic primary alcohols purified from beeswax, with mild anti-inflammatory and effective antiulcer effects experimentally proved. Furthermore, it reduces leukotriene (LTB(4)) in the exudate of carrageenan-induced pleurisy and has a protective effect on the pre-ulcerative phase of carrageenan-induced colonic ulceration in the guinea pig. This study was conducted to determine the effect of D-002 on acetic acid-induced colitis in rats at single and repeated doses. In a first series, D-002 was orally administered at 25 and 50 mg kg(-1), 24 h before the induction of colitis, meanwhile, in a second series, it was administered 24 h after the induction of colitis. Two other series (III and IV) examined the protective and therapeutic effect of D-002 administered for 7 days at the same doses, before or after colitis induction. Significant reductions in wet weight, macroscopic injury, polymorphonuclear infiltration and wall thickness were observed in colonic mucosa of D-002-treated animals compared with controls in both protective and therapeutic alternatives. It is concluded that D-002 was effective to protect or prevent the damage associated to acetic acid-induced colitis.
authors.affiliation: Department of Pharmacology, Laboratory of Histology, Center of Natural Products, National Center for Scientific Research, 25 Ave and 158 Street, Playa, Havana, Cuba.
authors.forename: M
authors.initials: M
authors.lastname: Noa
authors.forename: R
authors.initials: R
authors.lastname: Más
authors.forename: D
authors.initials: D
authors.lastname: Carbajal
authors.forename: S
authors.initials: S
authors.lastname: Valdés
mesh_terms: D000085:Acetates / Q000008:administration & dosage; D000818:Animals; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003092:Colitis / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology; D005233:Fatty Alcohols / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D020556:Neutrophil Infiltration / Q000187:drug effects; D009929:Organ Size / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D000085:Acetates; D000897:Anti-Ulcer Agents; C104511:D 002; D005233:Fatty Alcohols